NASDAQ:DTIL

Precision Biosciences Stock Forecast

etoro logo Buy DTIL
*Your capital is at risk
$8.18
+0.300 (+3.81%)
At Close: Jul 02, 2026
AI Analysis AI Analysis of DTIL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DTIL to Watchlist?
Some Reasons Why To Add DTIL:
  • High gross margin of 97.0%
  • +88.5% price growth over the last year
  • +99.5% YTD performance
PDF

Precision BioSciences Inc. stock price ended at $8.18 on Thursday, after gaining 3.81%
(Updated on Jul 02, 2026)

Buy or Hold candidate since Jun 22, 2026 Gain 15.54%

The Precision BioSciences Inc. stock price gained 3.81% on the last trading day (Thursday, 2nd Jul 2026), rising from $7.88 to $8.18. During the last trading day the stock fluctuated 5.04% from a day low at $7.85 to a day high of $8.24. The price has risen in 7 of the last 10 days and is up by 25.85% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 146 thousand more shares were traded than the day before. In total, 590 thousand shares were bought and sold for approximately $4.83 million.

The stockis at the upper part of a very wide and horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $8.26 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect Precision BioSciences Inc. stock with a 90% probability to be traded between $5.89 and $8.12 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

DTIL Signals & Forecast

Mostly positive signals in the chart today. The Precision BioSciences Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $7.52 and $7.01. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 35.43%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Precision BioSciences Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $7.59 and $7.29. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Precision BioSciences Inc. finds support just below today's level at $7.59. If this is broken, then the next support from accumulated volume will be at $7.29 and $6.77.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.395 between high and low, or 5.04%. For the last week, the stock has had daily average volatility of 7.95%.

The Precision BioSciences Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $7.74 (-5.32%) (This stock has high daily movements and this gives high risk. The RSI14 is 84 and this increases the risk substantially. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (DTIL) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Precision BioSciences Inc. to open at $8.09, and during the day (based on 14 day Average True Range), to move between $7.91 and $8.45, which gives a possible trading interval of +/-$0.538 (+/-6.81%) up or down from last closing price. If Precision BioSciences Inc. takes out the full calculated possible swing range there will be an estimated 6.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.20 (0.24%) than the support at $7.59 (7.21%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Precision BioSciences Inc. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Precision BioSciences Inc. stock to perform well in the short-term period.

Current score: 3.476 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $8.09 ( 1.12%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DTIL Performance

Trading levels for DTIL

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 8.48 3.71%
R2 8.33 1.86%
R1 8.24 0.724%
Price 8.18
S1 7.94 -2.97%
S2 7.84 -4.10%
S3 7.69 -5.95%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 8.34 1.96%
R1 8.20 0.244%
Price 8.18
S1 7.59 -7.21%
S2 7.29 -10.88%
S3 6.77 -17.24%

FAQ

What is the symbol for Precision BioSciences Inc. Stock and on which exchange is it traded?
The symbol for Precision BioSciences Inc. is DTIL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Precision BioSciences Inc. Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Precision BioSciences Inc. stock to perform well in the short-term period.

How to buy Precision BioSciences Inc. Stock?
Precision BioSciences Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Precision BioSciences Inc. Stock.

What's the current price of Precision BioSciences Inc. Stock?
As of the end of day on the Jul 02, 2026, the price of an Precision BioSciences Inc. (DTIL) share was $8.18.

What is the 52-week high and low for Precision BioSciences Inc. Stock?
The 52-week high for Precision BioSciences Inc. Stock is $8.81 and the 52-week low is $3.53.

What is the market capitalization of Precision BioSciences Inc. Stock?
As of the Jul 02, 2026, the market capitalization of Precision BioSciences Inc. is 104.934M.

When is the next earnings date for Precision BioSciences Inc.?
The upcoming earnings date for Precision BioSciences Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT PRECISION BIOSCIENCES INC.
Precision BioSciences
Precision BioSciences, Inc., a clinical stage gene editing company, develops vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which a specific type of immune cell, called a T cell, is genetica...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE